Faculty of Human, Social, and Political Science, University of Cambridge

The 4th World Science and Technology Development Forum Held in Chengdu

Retrieved on: 
Monday, November 28, 2022
Technology, Mobile, Wireless, Software, Research, Science, Internet, Hardware, COVID-19, Food security, CAE, Multimedia, Chinese Academy of Sciences, CAST, Sustainability, Climate change, Artificial intelligence, Faculty of Human, Social, and Political Science, University of Cambridge, Sustainable development, Trust, Chinese Academy of Engineering, Speech, Biodiversity, Poverty, CAS, Renewable energy, Management, Science, Chemistry

View the full release here: https://www.businesswire.com/news/home/20221128005539/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221128005539/en/
    The 4th World Science and Technology Development Forum Held in Chengdu (Photo: Business Wire)
    The world today is facing many challenges, such as the COVID-19 pandemic, energy security, food security, climate change, poverty, and biodiversity, which urgently need to be addressed by the international community.
  • Hou Jianguo, President of the Chinese Academy of Sciences, remarked in his speech, How to achieve sustainable development is facing all mankind.
  • The 4th World Science and Technology Development Forum is jointly organized by China Association of Science and Technology (CAST), Chinese Academy of Sciences (CAS), Chinese Academy of Engineering (CAE) and The People's Government of Sichuan Province.
  • Having been held successfully for three consecutive years, the forum is actively building a bridge connecting the global science and technology community and has become an open platform to better advocate and promote cooperation among the international science and technology community.

Mallinckrodt Announces Appointment of Susan Silbermann to its Board of Directors

Retrieved on: 
Thursday, October 6, 2022
U.S. Securities and Exchange Commission, The Company, Writer, NGO, SEC, Faculty of Human, Social, and Political Science, University of Cambridge, General manager, Ophthalmology, Emerging market, Vaccine, Education, Politics, Annual report, Patient, Tufts University, Commercial, IAVI, Region, Risk, Senior, Private Securities Litigation Reform Act, Infection, Social, Administration, Company, Trade, Analgesic, Neurology, Ajman Specialty General Hospital, Board, International business, Safety, Immunotherapy, Board of directors, Rheumatology, HIV-AIDS, Autoimmunity, COVID-19, Nephrology, Public health, Management, Pharmaceutical industry, Marketing, Pfizer, Biology, New York University, Mallinckrodt

DUBLIN, Oct. 6, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has appointed Susan Silbermann to its Board of Directors, effective October 5, 2022.

Key Points: 
  • DUBLIN, Oct. 6, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today announced that it has appointed Susan Silbermann to its Board of Directors, effective October 5, 2022.
  • With the addition of Ms. Silbermann, the Mallinckrodt Board will expand to nine directors, eight of whom are independent.
  • "Susan is a highly respected and deeply experienced global executive in the healthcare industry, and we are pleased to welcome her to Mallinckrodt's Board," said Paul Bisaro, Chairman of the Mallinckrodt Board of Directors.
  • "I am excited to join the Mallinckrodt Board at this transformative moment for the Company," said Ms. Silbermann.